Home / Uncategorized / FDA panel: Nix Avastin’s use for breast cancer

FDA panel: Nix Avastin’s use for breast cancer

Final decision lies with FDA commissioner, but unanimous vote to withdraw widely-used cancer drug is significant

Read more:
FDA panel: Nix Avastin’s use for breast cancer

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top